MEDVF — Medivolve Cashflow Statement
0.000.00%
Last trade - 00:00- $0.35m
- $1.07m
- CA$0.69m
Annual cashflow statement for Medivolve, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.72 | -37.8 | -6.61 | -18.4 | -16.7 |
| Depreciation | |||||
| Non-Cash Items | -0.509 | 21.4 | 16.3 | 10.4 | 11.9 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.15 | 2.27 | -23.8 | 12.5 | 1.52 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.38 | -11 | -9.32 | 6.04 | -2.89 |
| Capital Expenditures | 0 | -0.414 | -0.043 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -5.07 | -0.584 | 0 | -0.239 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -5.49 | -0.626 | 0 | -0.239 |
| Financing Cash Flow Items | — | -0.211 | -0.452 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | 17.3 | 9.21 | -1.89 | -0.332 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.38 | 0.85 | -0.739 | 4.16 | -3.47 |